O'Shaughnessy Asset Management, LLC Celldex Therapeutics, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

  • $10.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$35.68 - $56.27 $92,875 - $146,470
-2,603 Closed
0 $0
Q3 2021

Nov 10, 2021
BUY
$28.95 - $55.99 $73,475 - $142,102
2,538 Added 3904.62%
2,603 $141,000
Q1 2021

May 14, 2021
SELL
$16.19 - $29.91 $97 - $179
-6 Reduced 8.45%
65 $1,000
Q4 2020

Feb 11, 2021
BUY
$14.99 - $22.75 $809 - $1,228
54 Added 317.65%
71 $1,000
Q3 2020

Nov 12, 2020
BUY
$9.65 - $15.19 $164 - $258
17 New
17 $0

Others Institutions Holding CLDX

# of Institutions
203
Shares Held
66M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.19B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email